Simon Bomken Consultant Paediatric Oncologist Newcastle

Simon Bomken Consultant Paediatric Oncologist Newcastle – Leading Expert in Childhood Lymphomas

Simon Bomken Consultant Paediatric Oncologist Newcastle is a trusted expert in childhood cancer care. He serves as an honorary Consultant at the Great North Children’s Hospital, where he focuses on Non-Hodgkin lymphoma, immune-dysregulation associated lymphoproliferation, and histiocytic disorders. As an MRC clinician scientist fellow, he combines compassionate patient care with innovative research.

Consultant Paediatric Oncologist Newcastle: Clinical Excellence and Research Impact

Dr. Bomken treats some of the most complex childhood lymphoma cases. At the Great North Children’s Hospital, he delivers cutting-edge therapies while supporting families throughout treatment. His dual role in clinical care and laboratory science allows him to translate research breakthroughs directly into improved patient outcomes.

In addition, Dr. Bomken co-leads the lymphoma research group at the Wolfson Childhood Cancer Research Centre. Their team investigates childhood Non-Hodgkin lymphomas, from identifying genetic markers to testing new therapies in pre-clinical models. This research drives real progress in developing safer, more effective treatments.

A Leader in Immune-Dysregulatory Lymphoproliferation Research

Beyond lymphoma, Dr. Bomken studies lymphoproliferative disorders linked to immune-dysregulation. These include post-transplant complications and conditions associated with primary immunodeficiencies. By focusing on this highly specialized area, he advances understanding of rare but serious conditions. The lab also supports both clinical and non-clinical research students, nurturing the next generation of cancer researchers.

Simon Bomken Consultant Paediatric Oncologist Newcastle: Driving National and Global Collaboration

Dr. Bomken actively shapes the national research landscape. He chairs the CCLG Non-Hodgkin Lymphoma Interest Group and sits on the NCRI’s childhood NHL and lymphoma biology panels. These roles ensure his work directly informs UK cancer research strategy.

Internationally, he is a member of EICNHL, iBFM, and SIOPe. Through these collaborations, he contributes to global studies aimed at improving survival and quality of life for children with lymphoma. His commitment to collaboration ensures patients benefit from the latest advances no matter where they live.

Training, Mentorship, and the Future of Paediatric Oncology

Dr. Bomken believes deeply in mentoring the next generation of paediatric oncologists and scientists. His lab fosters growth through hands-on research experience. This dedication to teaching ensures that children with cancer will continue to receive world-class care and innovation well into the future.